<DOC>
	<DOCNO>NCT02800005</DOCNO>
	<brief_summary>As number obesity continue increase , surgical oncologist pay attention effect obesity surgical outcome survival digestive systemin cancer . Body mass index ( BMI ) one widely use measurement obesity . Abdominal fat area ( AFA ) calculate computed tomography popular validity fat distribution . There still consensus BMI AFA could effective measurement accurate evaluate effect obesity surgical outcome survival . Gastric cancer one common digestive system cancer , gastrectomy primary therapeutic options.It important compare different measurement ( BMI AFA ) ass obesity effect surgical outcome survival gastric cancer patient .</brief_summary>
	<brief_title>Effect Obesity Surgical Outcomes Survival Gastric Cancer</brief_title>
	<detailed_description>Standard operation procedure（SOP） 1 . Preoperative evaluation Patients satisfied inclusion/exclusion criterion inform join clinical study signature inform consent . 2 . Procedures : The surgical treatment adopt total subtotal gastrectomy accord Japanese Gastric Cancer treatment guideline , 2010 , Version 3 . 3 . Postoperative recovery : Postoperative recovery period need collect relevant parameter patient . All relevant parameter definitely definition Case Report Form study include preoperative , intraoperative postoperative clinicopathologic characteristic . 4 . Follow-up : Follow-up last 5-year postoperative period . The postoperative complication grade clavian-dildo classification . The postoperative complication quality life ( change AFA , performance status , recurrence overall survival ) focus study .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Preoperative endoscopy biopsy confirm gastric adenocarcinoma , predictively feasible conventional open total gastrectomy subtotal gastrectomy ; 2 . Predictively resectable disease , preoperative stag Japanese Gastric Cancer Association 14th Edition clinical T1N0M0T4aN+M0 ; 3 . Age：≤75 year , ≥18 year ; 4 . Without serious disease malignance disease ; 5 . Without history abdominal surgery ; 6 . World Health Organization performance score ≤2 , American Society Anesthesiologists score ≤3 ; 7 . No limit sexual race ; 8 . Informed consent require ; 9 . Obesity define BMI≧30kg/m2 preoperative AFA≧100cm2/cm . 1 . Patients severe complication tolerate surgery : severe heart lung disease , heart function clinical stage 2 , uncontrollable hypertension , pulmonary infection , moderate severe chronic obstructive pulmonary disease , chronic bronchitis , severe diabetes / renal insufficiency , severe hepatitis / function rank CHILD B grade , severe malnutrition , etc ; 2 . Patients treat neoadjuvant chemotherapy radiation therapy might affect efficacy observation ; 3 . Severity mental disease ; 4 . Primary lesion resect pattern transabdominal gastrectomy , Whipple 's procedure , transthoracic approach surgery ; 5 . After signature Clinical trial agreement , patient agent quit trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>gastrectomy</keyword>
	<keyword>laparotomy</keyword>
	<keyword>surgical outcome</keyword>
	<keyword>survival</keyword>
	<keyword>abdominal fat area</keyword>
	<keyword>Body Mass Index</keyword>
</DOC>